Jagsonpal Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is primarily engaged in the manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients (APIs). Its Gynaecology products include Divatrone, Endoreg, Cystelia-M, Fibristone, Yuliprist, Deereg, and Lycored Softgel. Its Orthopaedics products include JP Tone Up, Metadec 50 Injection, Metadec 25 Injection, Indocap SR, and Indocap, Colla-2. Its other products include Equirex, Doxypal DR-L, JP Tone Syrup, and Lycored Syrup.As of 24 Jun 2026, Jagsonpal Pharmaceuticals share price is ₹229.91. The stock opened at ₹232.02, compared to its previous close of ₹231.91. During today's trading session, Jagsonpal Pharmaceuticals share price moved in the range of ₹226.86 to ₹236.79, with an average price of ₹231.82 for the day. Looking at its last 52-week, the stock has touched a low of ₹226.86 and a high of ₹236.79. On the performance front, Jagsonpal Pharmaceuticals share price has increased by 14.90% over the last six months and is up 5.99% on a year-on-year basis.
The market capitalization of Jagsonpal Pharmaceuticals is ₹1,521 Crs, with a P/E ratio of 35.3 and a dividend yield of 1.76%.